Drug: Nabiximols: chronic pain clinical trials
Registry records that list "Drug: Nabiximols" as an intervention. Being studied does not mean an intervention works or is approved.
0
Trials with Canadian sites
0
Recruiting in Canada
4
Registry records in total
Trials in Canada
No trial with a Canadian site lists this intervention in this snapshot.
Trials worldwide (outside Canada)
4 trials, 0 recruiting or not yet recruiting. Recruiting first.
| Phase | Countries | ||||
|---|---|---|---|---|---|
| A Two-Part Study of Sativex® Oromucosal Spray for Relieving Uncontrolled Persistent Pain in Patients With Advanced Cancer NCT01424566 | Completed | Phase 3 | Australia, Bulgaria, Germany, Hungary and 9 more | Jazz Pharmaceuticals | 2012-06-29 |
| Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer NCT01361607 | Completed | Phase 3 | Bulgaria, Czechia, Germany, Hungary and 6 more | Jazz Pharmaceuticals | 2011-05-27 |
| Long Term Safety of Sativex Oromucosal Spray (Sativex®; Nabiximols) as Adjunctive Therapy in Patients With Uncontrolled Persistent Chronic Cancer Related Pain NCT01337089 | Completed | Phase 3 | Australia, Belgium, Bulgaria, Czechia and 14 more | Jazz Pharmaceuticals | 2011-01-19 |
| Sativex® for Relieving Persistent Pain in Participants With Advanced Cancer NCT01262651 | Completed | Phase 3 | Belgium, Bulgaria, Czechia, Germany and 8 more | GW Pharmaceuticals Ltd | 2010-11-25 |
Conditions studied with this intervention
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status.